BBIO CIK: 1743881

BridgeBio Pharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.89
FY22:
0.55
FY23:
0.48
FY24:
0.72
FY25:
0.80
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.07
FY23:
0.07
FY24:
0.20
FY25:
0.14
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.01
FY22:
0.62
FY23:
0.55
FY24:
0.92
FY25:
0.94

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.14
FY22:
0.12
FY23:
0.14
FY24:
0.15
FY25:
0.29
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.74
FY22:
1.75
FY23:
1.75
FY24:
2.22
FY25:
2.72
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.87
FY22:
−1.25
FY23:
−1.35
FY24:
−1.47
FY25:
−2.09

All amounts in billions USD Data sources:SEC EDGARTwelve Data